molecular beacon probes-base multiplex nasba real-time for detection of hiv-1 and hcv.

developed in 1991, nucleic acid sequence-based amplification (nasba) has been introduced as a rapid molecular diagnostic technique, where it has been shown to give quicker results than pcr, and it can also be more sensitive. this paper describes the development of a molecular beacon-based multiplex nasba assay for simultaneous detection of hiv-1 and hcv in plasma samples.a well-conserved region in the hiv-1 pol gene and 5'-ncr of hcv genome were used for primers and molecular beacon design. the performance features of hcv/hiv-1 multiplex nasba assay including analytical sensitivity and specificity, clinical sensitivity and clinical specificity were evaluated.the analysis of scalar concentrations of the samples indicated that the limit of quantification of the assay was <1000 copies/ml for hiv-1 and <500 copies/ml for hcv with 95% confidence interval. multiplex nasba assay showed a 98% sensitivity and 100% specificity. the analytical specificity study with blast software demonstrated that the primers do not attach to any other sequences except for that of hiv-1 or hcv. the primers and molecular beacon probes detected all hcv genotypes and all major variants of hiv-1.this method may represent a relatively inexpensive isothermal method for detection of hiv-1/hcv co-infection in monitoring of patients.